Sun Pharma Laboratories Ltd. v. Perilla Life Science P. Ltd. & Anr.
Case brief
What is this about?
Consent/settlement-based resolution of a Delhi High Court commercial trademark-infringement suit: Sun Pharma Laboratories Ltd. (plaintiff) v. Perilla Life Science P. Ltd. & Anr. (defendants), CS(COMM) 460/2023, decided 17.07.2025 by Amit Bansal J. After hearing on summary judgment application I.A. 36685/2024, the defendants discontinued use of marks G-VER and G-VAR and undertook to pay Rs.5,00,000/- as damages and costs. Decree of permanent injunction passed per prayers 31(a)/(b); Rs.5,00,000/- payable within two months, failing which 9% per annum interest applies; decree sheet to be drawn; 100% court-fee refund certificate per s.16 Court Fees Act, 1870. Keywords: trademark infringement, G-VER, G-VAR, summary judgment, permanent injunction, damages and costs, court fees refund, settlement.
What did the court decide?
Permanent injunction against the defendants' use of the marks 'G-VER' and 'G-VAR' in terms of prayer clauses 31(a) and 31(b); payment of Rs.5,00,000/- towards damages and costs within two months in satisfaction of prayer clauses 31(d) and 31(e), with interest @9% per annum on default; and a certificate of refund of 100% court fees under Section 16 of the Court Fees Act, 1870.